Posted by Michael Wonder on 18 Nov 2020
TGA grants third provisional determination for a COVID-19 vaccine
18 November 2020 - On 16 November 2020 the TGA granted a provisional determination to Janssen Cilag in relation to its COVID-19 vaccine, Ad26.COV2.S.
The granting of a provisional determination means that the TGA has made a decision that Janssen is now eligible to apply for provisional registration for the vaccine in the Australian Register of Therapeutic Goods.
